Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

Key Points Company and Industry Information 1. Company: Amgen Inc. (NASDAQ: AMGN) 2. Event: 43rd Annual J.P. Morgan Healthcare Conference 2025 3. Date: January 13, 2025 4. Time: 6:00 PM ET 5. Participants: - Robert Bradway - Chairman, CEO & President of Amgen - Chris Schott - JPMorgan Core Views and Arguments 1. Focus on Serious Diseases: Amgen is committed to addressing serious diseases, including heart attack, stroke, cancer, osteoporosis, and various rare diseases. 2. Portfolio of Medicines: The company has a portfolio of 38 innovative and biosimilar medicines, each contributing significantly to combating these diseases. 3. Confidence in Growth Outlook: Amgen is confident about the growth prospects of its business, driven by the quality of its medicine portfolio. Other Important Content 1. Community Support: Amgen expressed concern and solidarity with the community affected by wildfires in Southern California, committing to contribute $10 million to the rebuilding efforts. 2. Company History: Amgen has been based in Southern California for over 40 years.